XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.3

COMMON EQUITY (Tables)

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the nine months ended September 30, 2025, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type						Number of Awards
Stock options (1)						231,024
Restricted shares (2)						79,170
Performance units						185,945

(1)Stock options awarded had a weighted-average exercise price of $94.55 and a weighted-average grant date fair value of $18.23 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $94.55 per share.

Schedule of Common Stock Outstanding Roll Forward

We had the following changes to our outstanding common stock during the three and nine months ended September 30, 2025 and 2024:

						Three Months Ended September 30												Nine Months Ended September 30
						2025						2024						2025						2024
Common stock shares outstanding at beginning of period						321,866,395						316,079,401						317,680,855						315,434,531
Shares issued:
At-the-market offering program						3,075,416						—						6,579,783						—
Stock-based compensation						196,997						137,936						587,111						300,602
401(k)						70,200						38,400						185,300						285,000
Stock investment plan						85,244						98,709						261,203						334,313
Common stock shares outstanding at end of period						325,294,252						316,354,446						325,294,252						316,354,446

Schedule of Earnings Per Share, Basic and Diluted

The following table shows the computation of our basic and diluted EPS for the three and nine months ended September 30, 2025 and 2024:

						Three Months Ended September 30												Nine Months Ended September 30
(in millions)						2025						2024						2025						2024
Numerator:
Net income attributed to common shareholders						$	271.3					$	240.1					$	1,240.9					$	1,073.7
Denominator:
Weighted average basic shares outstanding						323.5						316.2						320.7						315.9
Dilutive effect of stock-based compensation awards						0.5						0.3						0.5						0.3
Dilutive effect of convertible senior notes						1.6						—						1.2						—
Weighted average diluted shares						325.6						316.5						322.4						316.2
Basic EPS						$	0.84					$	0.76					$	3.87					$	3.40
Diluted EPS						$	0.83					$	0.76					$	3.85					$	3.40

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number of equity awards granted during the period, including the weighted-average grant-date fair value and the weighted-average exercise price per award.

+ References

No definition available.

+ Details

Name:	wec_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantedinPeriodTableTextBlock
Namespace Prefix:	wec_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration